Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 12.6 CHF -3.08% Market Closed
Market Cap: CHf72.7m

Wall St Price Targets

XLS Price Targets Summary
Xlife Sciences AG

Wall Street analysts forecast XLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XLS is 31.62 CHF with a low forecast of 31.31 CHF and a high forecast of 32.55 CHF.

Lowest Forecast
Price Target
31.31 CHF
148% Upside
Average Forecast
Price Target
31.62 CHF
151% Upside
Highest Forecast
Price Target
32.55 CHF
158% Upside
Xlife Sciences AG Competitors:
Price Targets
MRKR
Marker Therapeutics Inc
580% Upside
TES
Tesmec SpA
26% Upside

Revenue
Forecast

20% / Year
Past Growth
-1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
20% / Year
Past Growth
-1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is -1%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Xlife Sciences AG

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
99%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
99%
Average Beat

Pre-Tax Income
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 3%.

Net Income
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Net Income has been 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is XLS's stock price target?
Price Target
31.62 CHF

According to Wall Street analysts, the average 1-year price target for XLS is 31.62 CHF with a low forecast of 31.31 CHF and a high forecast of 32.55 CHF.

What is the Revenue forecast for Xlife Sciences AG?
Projected CAGR
-1%

Over the last 4 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is -1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett